Phathom Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
Phathom Pharmaceuticals (Nasdaq: PHAT) has announced its participation in the 24th Annual Needham Virtual Healthcare Conference. The company's management team will engage in a fireside chat on Tuesday, April 8th, 2025, at 10:15 am ET.
The conference, scheduled to run from April 7-10, 2025, will also feature one-on-one meetings with company management. A live webcast and archived recording of the event will be accessible through the Events & Presentations section of Phathom's website, with the recording remaining available for 90 days after the meeting.
Phathom Pharmaceuticals is a biopharmaceutical company specializing in the development and commercialization of novel treatments for gastrointestinal (GI) diseases.
Phathom Pharmaceuticals (Nasdaq: PHAT) ha annunciato la sua partecipazione alla 24ª Conferenza Virtuale Annuale di Needham sulla Salute. Il team di gestione dell'azienda parteciperà a una chiacchierata informale il martedì 8 aprile 2025, alle 10:15 ET.
La conferenza, prevista dal 7 al 10 aprile 2025, includerà anche incontri individuali con la direzione dell'azienda. Una trasmissione in diretta e una registrazione archiviata dell'evento saranno accessibili tramite la sezione Eventi e Presentazioni del sito web di Phathom, con la registrazione disponibile per 90 giorni dopo l'incontro.
Phathom Pharmaceuticals è un'azienda biofarmaceutica specializzata nello sviluppo e nella commercializzazione di trattamenti innovativi per le malattie gastrointestinali (GI).
Phathom Pharmaceuticals (Nasdaq: PHAT) ha anunciado su participación en la 24ª Conferencia Virtual Anual de Needham sobre Salud. El equipo directivo de la empresa participará en una charla informal el martes 8 de abril de 2025, a las 10:15 am ET.
La conferencia, programada del 7 al 10 de abril de 2025, también contará con reuniones individuales con la dirección de la empresa. Una transmisión en vivo y una grabación archivada del evento estarán disponibles a través de la sección de Eventos y Presentaciones del sitio web de Phathom, con la grabación accesible durante 90 días después de la reunión.
Phathom Pharmaceuticals es una empresa biofarmacéutica especializada en el desarrollo y comercialización de tratamientos novedosos para enfermedades gastrointestinales (GI).
Phathom Pharmaceuticals (Nasdaq: PHAT)는 제24회 니드햄 연례 가상 의료 회의에 참가한다고 발표했습니다. 회사의 경영진은 2025년 4월 8일 화요일, 오전 10시 15분 ET에 화상 대화에 참여할 예정입니다.
이번 회의는 2025년 4월 7일부터 10일까지 진행되며, 회사 경영진과의 일대일 미팅도 포함됩니다. 이벤트의 라이브 웹캐스트 및 녹화된 내용은 Phathom의 웹사이트의 이벤트 및 발표 섹션을 통해 접근할 수 있으며, 회의 후 90일 동안 녹화된 내용이 제공됩니다.
Phathom Pharmaceuticals는 위장관(GI) 질환에 대한 새로운 치료법 개발 및 상용화에 전문화된 생명공학 제약 회사입니다.
Phathom Pharmaceuticals (Nasdaq: PHAT) a annoncé sa participation à la 24e Conférence Virtuelle Annuelle de Needham sur la Santé. L'équipe de direction de l'entreprise participera à une discussion informelle le mardi 8 avril 2025, à 10h15 ET.
La conférence, prévue du 7 au 10 avril 2025, comprendra également des réunions individuelles avec la direction de l'entreprise. Un webinaire en direct et un enregistrement archivé de l'événement seront accessibles via la section Événements et Présentations du site Web de Phathom, l'enregistrement restant disponible pendant 90 jours après la réunion.
Phathom Pharmaceuticals est une entreprise biopharmaceutique spécialisée dans le développement et la commercialisation de traitements novateurs pour les maladies gastro-intestinales (GI).
Phathom Pharmaceuticals (Nasdaq: PHAT) hat seine Teilnahme an der 24. jährlichen virtuellen Gesundheitskonferenz von Needham bekannt gegeben. Das Management-Team des Unternehmens wird am Dienstag, den 8. April 2025, um 10:15 Uhr ET an einem informellen Gespräch teilnehmen.
Die Konferenz, die vom 7. bis 10. April 2025 stattfindet, wird auch Einzelgespräche mit dem Management des Unternehmens umfassen. Ein Live-Webcast und eine archivierte Aufnahme der Veranstaltung werden über den Bereich Veranstaltungen & Präsentationen auf der Website von Phathom zugänglich sein, wobei die Aufnahme 90 Tage nach dem Treffen verfügbar bleibt.
Phathom Pharmaceuticals ist ein biopharmazeutisches Unternehmen, das sich auf die Entwicklung und Vermarktung neuartiger Behandlungen für gastrointestinale (GI) Erkrankungen spezialisiert hat.
- None.
- None.
FLORHAM PARK, N.J., April 03, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that members of the management team will participate in a fireside chat at the 24th Annual Needham Virtual Healthcare Conference on Tuesday, April 8th, 2025, at 10:15 am ET.
Company management will also participate in one-on-one meetings during the conference, which will run from April 7-10, 2025.
To access the live webcast and archived recording of the event, visit the Events & Presentations section of the Phathom website at https://investors.phathompharma.com/news-events/events-and-presentations. The recording will be available for 90 days following the conclusion of the meeting.
About Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of novel treatments for gastrointestinal diseases. Phathom has in-licensed the exclusive rights to vonoprazan, a first-in-class potassium-competitive acid blocker (PCAB) that is currently marketed in the United States as VOQUEZNA® (vonoprazan) tablets for the relief of heartburn associated with Non-Erosive GERD in adults, the healing and maintenance of healing of Erosive GERD in adults and relief of associated heartburn, in addition to VOQUEZNA® TRIPLE PAK® (vonoprazan tablets, amoxicillin capsules, clarithromycin tablets) and VOQUEZNA® DUAL PAK® (vonoprazan tablets, amoxicillin capsules) for the treatment of H. pylori infection in adults. For more information about Phathom, visit the company’s website at www.phathompharma.com and follow on LinkedIn and X.
MEDIA CONTACT
Nick Benedetto
1-877-742-8466
media@phathompharma.com
INVESTOR CONTACT
Eric Sciorilli
1-877-742-8466
ir@phathompharma.com
© 2025 Phathom Pharmaceuticals. All rights reserved. VOQUEZNA, VOQUEZNA DUAL PAK, VOQUEZNA TRIPLE PAK, Phathom Pharmaceuticals, and their respective logos are registered trademarks of Phathom Pharmaceuticals, Inc.
FAQ
When is Phathom Pharmaceuticals (PHAT) presenting at the Needham Healthcare Conference 2025?
How long will the recording of PHAT's Needham Conference presentation be available?
Where can investors access PHAT's Needham Conference presentation webcast?
What is the duration of the 2025 Needham Healthcare Conference where PHAT is presenting?
What type of diseases does Phathom Pharmaceuticals (PHAT) focus on treating?
